Health Canada inspection
Amphastar France Pharmaceuticals: Health Canada inspection of Mar 6, 2026
Health Canada · GMP · rating I
Key facts
| Establishment | Amphastar France Pharmaceuticals |
|---|---|
| City | Eragny Sur Epte |
| Country | France |
| Program | GMP |
| Start date | Mar 6, 2026 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.